Cargando…
Serum levels of candidate microRNA diagnostic markers differ among the stages of non-small-cell lung cancer
Circulating microRNAs (miRNAs) are promising markers for cancer diagnosis and prognosis. Numerous studies evaluating miRNAs as markers for non-small cell lung cancer (NSCLC) have been conducted in recent years; however, the majority of candidate markers proposed via individual studies were inconsist...
Autores principales: | Aiso, Toshiko, Ohtsuka, Kouki, Ueda, Makiko, Karita, Shin, Yokoyama, Takuma, Takata, Saori, Matsuki, Naoko, Kondo, Haruhiko, Takizawa, Hajime, Okada, Annabelle A., Watanabe, Takashi, Ohnishi, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202492/ https://www.ncbi.nlm.nih.gov/pubmed/30405804 http://dx.doi.org/10.3892/ol.2018.9464 |
Ejemplares similares
-
5'‑isomiR is the most abundant sequence of miR‑1246, a candidate biomarker of lung cancer, in serum
por: Aiso, Toshiko, et al.
Publicado: (2023) -
A rad50 germline mutation induces tumorigenesis and ataxia-telangiectasia phenotype in a transparent medaka model
por: Chisada, Shinichi, et al.
Publicado: (2023) -
Pathological and Radiological Correlation in Prolonged Myeloperoxidase Anti-neutrophil Cytoplasmic Antibody-related Diffuse Alveolar Hemosiderosis
por: Saraya, Takeshi, et al.
Publicado: (2019) -
KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers
por: Yokoyama, Masaaki, et al.
Publicado: (2016) -
Use of a plasma test for verifying epidermal growth factor receptor gene (EGFR) mutations in fluid samples from non-small cell lung cancer patients()
por: Ogura, Wataru, et al.
Publicado: (2020)